Donnie Delarosa
Genomics Institute of the Novartis Research Foundation(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Cytokine Signaling Pathways and Interactions, T-cell and B-cell Immunology, Psoriasis: Treatment and Pathogenesis, HER2/EGFR in Cancer Research
Most-Cited Works
- → Function of CSF1 and IL34 in Macrophage Homeostasis, Inflammation, and Cancer(2019)196 cited
- → Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized mice(2010)109 cited
- → Lead Optimization of a 4-Aminopyridine Benzamide Scaffold To Identify Potent, Selective, and Orally Bioavailable TYK2 Inhibitors(2013)97 cited
- → Evaluation of heterophilic antibody blocking agents in reducing false positive interference in immunoassays for IL-17AA, IL-17FF, and IL-17AF(2010)33 cited
- → Identification of an imidazopyridine scaffold to generate potent and selective TYK2 inhibitors that demonstrate activity in an in vivo psoriasis model(2017)20 cited
- → Blockade of CSF-1 and IL-34 in mouse model of inflammatory arthritis and colitis show a pathogenic role for IL-34 (P5160)(2013)1 cited
- → A novel interleukin-10 antibody graft to treat inflammatory bowel disease(2025)1 cited
- → A sensitive immuno-PCR assay to measure a pro-inflammatory cytokine in human patient serum (P3243)(2013)1 cited
- → Evaluation of heterophilic antibody blocking agents in the development of sensitive immunoassays for IL-17AA, IL-17FF, and IL-17AF (38.24)(2009)
- → Specific targeting of PI 3-kinase p110δ for the treatment of rheumatoid arthritis (P5177)(2013)